Health care

Global Healthcare CX (Customer Experience) Market Analysis Report 2022: Digital CX Investments Driven by the Quadruple Aim in Healthcare - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 18, 2022 - 11:16am
Health, Health Insurance, Privacy, Investment, Confidentiality, Hospital, Health, Digital, Research, Solution, Industry, Patient, CX, Technology, Organization, Healthcare, Risk management, Health care

The "Digital CX Investments Driven by the Quadruple Aim in Healthcare, Global, 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digital CX Investments Driven by the Quadruple Aim in Healthcare, Global, 2022" report has been added to ResearchAndMarkets.com's offering.
  • The publisher surveyed decision-makers in the healthcare industry to discover investment plans over the next year.
  • Not surprisingly, the pandemic had a significant impact on customer experience (CX).
  • Contact centers were busy far beyond capacity, driving organizations of all sizes to accelerate investments in self-service channels and the cloud.

AccessFares Partners with Datamatics to Enhance Customer Experience for Their Premium International Airfare Services

Retrieved on: 
Thursday, August 18, 2022 - 11:23am
Software, Networks, Professional Services, Internet, Vacation, Data Management, Other Travel, Technology, Travel, Other Professional Services, Air, Transport, Other Technology, Business process automation, CLV, Media, Information Technology Services Agency, YouTube, International organization, Big data, Robotic process automation, Artificial intelligence, Big Media Publishers, Business process management, Financial services, Company, Twitter, EVP, Intelligent document, Business intelligence, Partnership, Digital electronics, Operation, BSE, Naval Facilities Engineering Service Center, Digital, Solution, Dell EMC Data Domain, LinkedIn, Customer, Sales, Online shopping, Insurance, Facebook, Datamatics, Health care

With this partnership, Datamatics aims to enhance customer experience by managing the premium international airfare services and help create value across the entire air-ticketing, invoicing & billing process.

Key Points: 
  • With this partnership, Datamatics aims to enhance customer experience by managing the premium international airfare services and help create value across the entire air-ticketing, invoicing & billing process.
  • As a part of the project, Datamatics will also implement query handling & resolution related to Ancillary Customer Services.
  • Datamatics (BSE: 532528 | NSE: DATAMATICS) a Digital Technologies, Operations and Experiences company that provides intelligent solutions for data-driven businesses to increase productivity and enhance the customer experience.
  • Datamatics services global customers across Banking, Financial Services, Insurance, Healthcare, Manufacturing, International Organizations, and Media & Publishing.

Melissa Hurst Practice Leader for Healthcare at Slone Partners

Retrieved on: 
Thursday, August 18, 2022 - 9:00am
People, Mentorship, Precision medicine, College, Professional development, Special, Hospital, University, Bachelor of Arts in Organizational Psychology, Doctor of Philosophy, Graduate, Health, Biotechnology, Executive search, Recruitment, Korn Ferry, Hurst, Consultant, Health care, Management

SOUTH RIDING, Va., Aug. 18, 2022 /PRNewswire-PRWeb/ -- Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced that Melissa Hurst has been named Practice Leader for Healthcare. With her extensive background in healthcare executive search, Hurst will focus on expanding the company's client base with hospitals, health systems, and academic centers. She will also retain her current title of Vice President of Executive Search in which she owns and leads executive level searches with a direct team of consultants whom she manages and mentors.

Key Points: 
  • SOUTH RIDING, Va., Aug. 18, 2022 /PRNewswire-PRWeb/ -- Slone Partners , a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced that Melissa Hurst has been named Practice Leader for Healthcare.
  • "Melissa Hurst is a very smart, talented, and experienced leader in healthcare executive search," said Slone Partners CEO Leslie Loveless .
  • "As Practice Leader, she will drive our strategic efforts to build out Slone Partners' healthcare client base and expand our partnerships with some of the most innovative and high-performing hospitals and health systems in the country."
  • Slone Partners delivers the leaders who build amazing and diverse life sciences and healthcare organizations People Are Our Science.

Tavneos® (avacopan) recommended by England’s NICE for the treatment of AAV (GPA/MPA)

Retrieved on: 
Thursday, August 18, 2022 - 6:00am
Health, Clinical Trials, Research, Pharmaceutical, Science, Biotechnology, Vasculitis, Receptor (biochemistry), Multimedia, Dialysis, Risk, NICE, Inflammation, C5a, National Health Service, Population, Neutrophil, Failure, University of Cambridge, ANCA, Atypical hemolytic uremic syndrome, ASX, Rituximab, European Commission, Steroid, CSL, Patient, Quality of life, Marketing, Cell, Hidradenitis suppurativa, Granulomatosis with polyangiitis, Anti-neutrophil cytoplasmic antibody, HS, Nephrology, MHRA, Prednisolone, Kidney, MPA, Fresenius Medical Care, GPA, Glucocorticoid, Lung, Microscopic polyangiitis, University, Cyclophosphamide, Time, Regulation of tobacco by the U.S. Food and Drug Administration, Medicine, Food, Adult, AAV, Disease, Health care, Pharmaceutical industry

We very much welcome NICEs decision, which means that eligible patients and clinicians have another choice of treatment for this debilitating condition.

Key Points: 
  • We very much welcome NICEs decision, which means that eligible patients and clinicians have another choice of treatment for this debilitating condition.
  • NICEs decision represents a major advancement for the treatment of GPA/MPA in the UK, said Prof. David Jayne, Professor of Clinical Autoimmunity, University of Cambridge.
  • Patients will now have access to a new therapy option that could help them optimize their treatment outcomes.
  • Tavneos was developed by ChemoCentryx, Inc., who is also developing Tavneos for the treatment of patients with C3 Glomerulopathy (C3G) and hidradenitis suppurativa (HS).

Prime Healthcare Services Announces Early Tender Results of Its Previously Announced Cash Tender Offer for 7.250% Senior Secured Notes Maturing November 2025 and Extends Total Consideration Pricing to the Expiration Date

Retrieved on: 
Thursday, August 18, 2022 - 12:54am
Practice Management, Insurance, Managed Care, Finance, Health, Hospitals, Professional Services, Health Insurance, Employee Retirement Income Security Act of 1974, Affordable Care Act, Risk, Mini-tender offer, Patient satisfaction, Expiration, Tender offer, Industry, Medicare, Rural Health Workforce and The Patient Protection and Affordable Care Act, Forward-looking statement, Health care, Health Insurance Portability and Accountability Act, Failure, Growth, Securities Exchange Act of 1934, Information, Sale, Hospital, Care Act 2014, Trade, Nursing, Public expenditure, Accountability Act, Patient, COVID-19, Company, Medicaid, Acquisition, Barclays Capital Inc. v. Theflyonthewall.com, Inc., Personal Information Agent, Barclays, Privacy, Securities Act of 1933, Tender, Physician, Insurance, Employment, National Association Medical Staff Services, Collection, Time, Pro rata, Participation, Person, Life insurance, Health insurance, Security (finance), Note

However, there can be no assurance that the conditions set forth in the Offer to Purchase will be satisfied or waived.

Key Points: 
  • However, there can be no assurance that the conditions set forth in the Offer to Purchase will be satisfied or waived.
  • The Tender Offer is described in the Offer to Purchase, dated August 4, 2022 (as it may be amended or supplemented, the Offer to Purchase).
  • The Tender Offer is subject to the satisfaction or waiver of a number of conditions as set forth in the Offer to Purchase.
  • Fourteen of the Prime Healthcare hospitals are members of the Prime Healthcare Foundation, a 501(c)(3) not-for-profit public charity.

RECELL® System Data to be Presented at the Controversies and Conversations in Laser & Cosmetic Surgery Annual Meeting

Retrieved on: 
Wednesday, August 17, 2022 - 9:50pm
Transfer, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Dermatology, AVH, Industry, Forward-looking statement, GLOBE, Failure, Technology, Growth, Clinical trial, CA, Burn, Regenerative medicine, USE, ASX, Avita Medical, Patient, MHS, Adult, Skin, Safety, Evidence, NASDAQ, Epidermis, PMA, Autotransplantation, Controversy, Burns, PMDA, Solution, MD, Light, Contraindication, Food, Vitiligo, Health care, Pharmaceutical industry, Medical device

Following review by the FDA, we believe the RECELL System may well offer a welcome treatment option for patients seeking repigmentation for stable vitiligo lesions.

Key Points: 
  • Following review by the FDA, we believe the RECELL System may well offer a welcome treatment option for patients seeking repigmentation for stable vitiligo lesions.
  • AVITA Medical is currently completing a pivotal trial for the use of the RECELL System for treatment of stable vitiligo.
  • The vitiligo clinical trial aims to demonstrate safe and effective repigmentation when using the RECELL System in combination with phototherapy.
  • AVITA Medicals first U.S. product, the RECELL System, was approved by the U.S. Food and Drug Administration (FDA) in September 2018.

Boston Heart Diagnostics Launches LipidSeq™-- An NGS Test for Common Genetic Disorders of Lipid Metabolism

Retrieved on: 
Wednesday, August 17, 2022 - 8:12pm
LCAT, Robarts Research Institute, Triglyceride, Cardiovascular disease, Multimedia, Disorder, Risk, Apolipoprotein, Lists of diseases, Hypercholesterolemia, HDL, Lipid metabolism, Tangier disease, Hypertriglyceridemia, Patient, View, NGS, Kidney, Sitosterolemia, Mutation, Lipidology, Health, Disease, Health care, Pharmaceutical industry, Eurofins Scientific, Familial dysbetalipoproteinemia

This saliva-based NGS test identifies the most common genetic causes of lipid and lipoprotein disorders.

Key Points: 
  • This saliva-based NGS test identifies the most common genetic causes of lipid and lipoprotein disorders.
  • Boston Heart Diagnostics announces the launch of LipidSeq, a revolutionary genetic test for cardiovascular disease.
  • Boston Heart is the only commercial laboratory able to test biochemical and genetic contributors when diagnosing inherited disorders of lipid metabolism (Reference: Schaefer EJ, Geller AS, Endress G. The biochemical and genetic diagnosis of lipid disorders.
  • For more information on Boston Heart Diagnostics, please visit www.BostonHeartDiagnostics.com
    View original content to download multimedia: https://www.prnewswire.com/news-releases/boston-heart-diagnostics-launch...

Forbes Recognizes AArete as one of World's Best Management Consulting Firms 2022

Retrieved on: 
Wednesday, August 17, 2022 - 7:12pm
Industry, CEO, Health care, Technology, Statista, Forbes, Conference on Semantics in Healthcare and Life Sciences, Twitter, List of life sciences, Empathy, World, LinkedIn, Consultant, Organization, Pharmaceutical industry

CHICAGO, Aug. 17, 2022 /PRNewswire/ -- AArete , a global management and technology consulting firm, has been named to the inaugural list of Forbes World's Best Management Consulting Firms 2022.

Key Points: 
  • CHICAGO, Aug. 17, 2022 /PRNewswire/ -- AArete , a global management and technology consulting firm, has been named to the inaugural list of Forbes World's Best Management Consulting Firms 2022.
  • The World's Best Management Consulting Firms 2022 list is the result of Statista's years of experience in evaluating the consulting market in numerous countries.
  • AArete was named to theForbeslist of America's Best Management Consulting Firms in 2021 and 2022, and was one of two firms featured in aForbes article for its work with healthcare clients.
  • AArete is a global management and technology consulting firm specializing in strategic profitability improvement, digital transformation, and advisory solutions.

PaceMate™ Co-Founders to Speak at HRX 2022, the Heart Rhythm Society's Cardiovascular Digital Health Summit

Retrieved on: 
Wednesday, August 17, 2022 - 7:09pm
Oak Room, Death, PST, CEO, Health care, RPM, Business development, Foundry products operations (Cincinnati Milling Machine), Heart Rhythm Society, Research, HRS, Patient, Pacem, Twitter, Education, CCDS, HRX, BSE, News, Interoperability, Science, Population health, Solution, LinkedIn, Medical device, Computer security

TAMPA, Fla., Aug. 17, 2022 /PRNewswire/ -- PaceMate, one of the nation's fastest-growing cardiac rhythm management and remote patient monitoring companies, announced two of its co-founders have been chosen to speak at HRX 2022, the Heart Rhythm Society's cardiovascular digital health summit on September 8-10, 2022, in San Diego, California. 

Key Points: 
  • TAMPA, Fla., Aug. 17, 2022 /PRNewswire/ -- PaceMate, one of the nation's fastest-growing cardiac rhythm management and remote patient monitoring companies, announced two of its co-founders have been chosen to speak at HRX 2022, the Heart Rhythm Society's cardiovascular digital health summit on September 8-10, 2022, in San Diego, California.
  • The first annual innovation-focused digital cardiovascular summit brings together 500 national innovators, including clinicians, engineers, product developers, investors, entrepreneurs, nonprofits, and patient advocacy groups, to examine transformative digital health trends and solutions to improve cardiovascular patient care.
  • "I am honored to be selected to speak at the Heart Rhythm Society's HRX digital health summit," said Tripp Higgins, CEO of PaceMate.
  • Incorporated in 1979 and based in Washington, D.C., it has a membership of more than 7,500 heart rhythm professionals in more than 90 countries worldwide.

Forbes Recognizes AArete as one of World's Best Management Consulting Firms 2022

Retrieved on: 
Wednesday, August 17, 2022 - 6:53pm
Multimedia, Industry, CEO, Health care, Technology, Statista, Forbes, Conference on Semantics in Healthcare and Life Sciences, Twitter, View, List of life sciences, Empathy, World, LinkedIn, Consultant, Organization, Pharmaceutical industry

CHICAGO, Aug. 17, 2022 /PRNewswire/ -- AArete , a global management and technology consulting firm, has been named to the inaugural list of Forbes World's Best Management Consulting Firms 2022.

Key Points: 
  • CHICAGO, Aug. 17, 2022 /PRNewswire/ -- AArete , a global management and technology consulting firm, has been named to the inaugural list of Forbes World's Best Management Consulting Firms 2022.
  • The World's Best Management Consulting Firms 2022 list is the result of Statista's years of experience in evaluating the consulting market in numerous countries.
  • AArete was named to theForbeslist of America's Best Management Consulting Firms in 2021 and 2022, and was one of two firms featured in aForbes article for its work with healthcare clients.
  • AArete is a global management and technology consulting firm specializing in strategic profitability improvement, digital transformation, and advisory solutions.